Keen Vision Acquisition Corporation (KVAC)
| Market Cap | 200.12M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| Shares Out | 19.37M |
| EPS (ttm) | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3 |
| Open | 10.34 |
| Previous Close | 10.34 |
| Day's Range | 10.33 - 10.36 |
| 52-Week Range | 10.14 - 10.99 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About KVAC
Keen Vision Acquisition Corporation intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, and related business combination with one or more businesses or entities. It intends to focus on businesses in the biotechnology, consumer goods, and agriculture sectors. The company was incorporated in 2021 and is based in Summit, New Jersey. [Read more]
News
Keen Vision Acquisition Corporation Announces the Separate Trading of its Ordinary Shares and Warrants, Commencing September 15, 2023
SUMMIT, N.J., Sept. 14, 2023 /PRNewswire/ -- Keen Vision Acquisition Corporation ("KVAC") announced today that, commencing September 15, 2023, holders of the units sold in the Company's initial public...
Keen Vision Acquisition IPO Registration Document (S-1)
Keen Vision Acquisition has filed to go public with an IPO on the NASDAQ.
New SPAC submits plans for $130M IPO, as another raises $60M
Two new biotech SPACs have come to town — and one of them has gone public.